Poseida Therapeutics Inc (PSTX)
3.21
-0.06
(-1.83%)
USD |
NASDAQ |
Nov 14, 16:00
3.21
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Organogenesis Holdings Inc | 77.58% |
| MaxCyte Inc | 76.38% |
| NovaBay Pharmaceuticals Inc | 66.33% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -111.0% |
| Return on Assets | -39.75% |
| Return on Invested Capital | -70.39% |
| Profit Margin (Quarterly) | -120.8% |
| Operating Margin (Quarterly) | -122.3% |
| Return on Net Operating Assets | -194.5% |